Beyond biventricular pacing: Exploring the advantages of his‐bundle pacing and left bundle branch pacing in heart failure—A systematic review and meta‐analysis

Abstract

AbstractBackgroundThis meta‐analysis compares His‐Purkinje system pacing (HPSP), a novel cardiac resynchronization therapy (CRT) technique that targets the intrinsic conduction system of the heart, with conventional biventricular pacing (BiVP) in heart failure (HF) patients with left ventricular (LV) dysfunction and dyssynchrony.MethodsWe searched multiple databases up to May 2023 and identified 18 studies (five randomized controlled trials and 13 observational studies) involving 1291 patients. The outcome measures were QRS duration, left ventricular ejection fraction (LVEF) improvement, left ventricular end‐diastolic diameter (LVEDD) change, HF hospitalization, and New York Heart Association (NYHA) functional class improvement. We used a random‐effects model to calculate odds ratios (OR), and mean differences (MD) with 95% confidence intervals (CI). We also assessed the methodological quality of the studies.ResultsThe mean LVEF was 30.7% and the mean follow‐up duration was 8.1 months. Among LBBP, HBP, and BiVP, HBP provided the shortest QRS duration [MD: −18.84 ms, 95% CI: −28.74 to −8.94; p = 0.0002], while LBBP showed the greatest improvement in LVEF [MD: 5.74, 95% CI: 2.74 to 7.46; p < 0.0001], LVEDD [MD: −5.55 mm, 95% CI: −7.51 to −3.59; p < 0.00001], and NYHA functional class [MD: −0.58, 95% CI: −0.80 to −‐0.35; p < 0.00001]. However, there was no significant difference in HF hospitalization between HPSP and BiVP.ConclusionLBBP as modality of HPSP demonstrated superior outcomes in achieving electrical ventricular synchrony and systolic function, as well as alleviating HF symptoms, compared to other pacing techniques.